Coronavirus Coronavirus COVID-19 Gilead Sciences Says Remdesivir Hit its Endpoint; Fauci Optimistic By Staff Reports 2 months ago Dr. Anthony Fauci reported on Gilead Sciences, Inc. who today announced topline results from the
Biotech Company News Gilead misses key goal in NASH liver disease trial By Staff Reports 1 year ago CHICAGO (Reuters) – Gilead Sciences Inc said on Monday that a late-stage study of a
Biotechnology cancer Cell Therapy Clinical Trials Gene Therapy Vanderbilt-Ingram Cancer Center Patients Treated with New FDA-Approved CAR T Therapy By Staff Reports 3 years ago Vanderbilt-Ingram Cancer Center (VICC) has been selected as one of the few authorized treatment centers
Pharmaceutical Business News Gilead to buy Kite Pharma in $11.9 billion deal By Staff Reports 3 years ago Reuters — Gilead Sciences agreed to buy Kite Pharma in a $11.9 billion deal on